Flipkart buys Jabong after Myntra

Date:

Volatility is a factor that is synonymous with the business world. This is evident is the increasing business sector of e-commerce. Fashion giant Jabong which was once considered to be the leading online fashion retailer started reporting losses and has been up for sale for a year now.

E-commerce leader Flipkart grabbed this opportunity and its subsidiary Myntra carried out Jabong’s acquisition only recently. The financial details of this deal have not been made available yet.

“Fashion and lifestyle is one of the biggest drivers of e-commerce growth in India. We have always believed in the fashion and lifestyle segment and Myntra’s strong performance has reinforced this faith. This acquisition is a continuation of the group’s journey to transform commerce in India. I am happy that we will now be able to offer to millions of customers a wide variety of styles, products and a broad assortment of global as well as Indian brands,” said Binny Bansal, co-founder of Flipkart.

Jabong offers more than 1,500 international high-street brands, sports labels, Indian ethnic and designer labels and over 150,000 styles from over a thousand sellers.

Jabong received a huge welcome at the Flipkart family.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

IPL 2024: SRH Qualifies For Playoffs As Match Against Gujarat Abandoned Due To Rain

Sunrisers Hyderabad have officially became the third team to qualify for playoffs

Three Year Old Dead After Parent’s Forget Her In Car, Attend Wedding

As per the police, the incident occurred on Wednesday evening and the girl has been identified as Gorvika Nagar

IPL 2024: Toss Delayed In Sunrisers Hyderabad-Gujarat Titans Clash Due To Rain

It will be a crucial match for the Hyderabad-based franchise since they have to win the match to qualify for the playoffs of the IPL 2024

Another Rare Blood Disorder Linked To AstraZeneca Covid Vaccine Found

Researchers have found that the AstraZeneca vaccine sold in India under the brand name Covishield is linked to a rare blood clotting disorder known as Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)